Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension

Heidi M. Mansour

doi:10.1177/2045894018809084

Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Journal	Pulmonary Circulation
Volume	8
Issue number	4
DOIs	https://doi.org/10.1177/2045894018809084
State	Published - Oct 1 2018

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1177/2045894018809084

Cite this

@article{68d13bfad82d433f9fcecd2e12561c36,

title = "Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension",

author = "Mansour, {Heidi M.}",

note = "Funding Information: HMM received an honorarium from MSP Corporation for her first inhalation webinar, an unrestricted education grant from Aerogen for a second inhalation webinar, and research support from Cureveda, DMV-Fonterra Excipients, GlaxoSmithKline, InSys Therapeutics, Oakwood Labs, and Pfizer. Funding Information: HMM gratefully acknowledges funding support from the National Institutes of Health (P01HL103453, 1R21AI135935, 1R44AG059279, 1R01HL137282, 1R21AG054766, RL5GM118969, TL4GM118971, and UL1GM118970) and the National Science Foundation (NSF Cooperative Agreement No. HRD-1101728).",

year = "2018",

month = oct,

day = "1",

doi = "10.1177/2045894018809084",

language = "English (US)",

volume = "8",

journal = "Pulmonary Circulation",

issn = "2045-8932",

publisher = "University of Chicago Press",

number = "4",

}

TY - JOUR

T1 - Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension

AU - Mansour, Heidi M.

N1 - Funding Information: HMM received an honorarium from MSP Corporation for her first inhalation webinar, an unrestricted education grant from Aerogen for a second inhalation webinar, and research support from Cureveda, DMV-Fonterra Excipients, GlaxoSmithKline, InSys Therapeutics, Oakwood Labs, and Pfizer. Funding Information: HMM gratefully acknowledges funding support from the National Institutes of Health (P01HL103453, 1R21AI135935, 1R44AG059279, 1R01HL137282, 1R21AG054766, RL5GM118969, TL4GM118971, and UL1GM118970) and the National Science Foundation (NSF Cooperative Agreement No. HRD-1101728).

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85055433053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055433053&partnerID=8YFLogxK

U2 - 10.1177/2045894018809084

DO - 10.1177/2045894018809084

M3 - Editorial

AN - SCOPUS:85055433053

SN - 2045-8932

VL - 8

JO - Pulmonary Circulation

JF - Pulmonary Circulation

IS - 4

ER -

Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this